145 related articles for article (PubMed ID: 18404447)
1. New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile.
Lambertucci C; Cristalli G; Dal Ben D; Kachare DD; Bolcato C; Klotz KN; Spalluto G; Volpini R
Purinergic Signal; 2007 Sep; 3(4):339-46. PubMed ID: 18404447
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of trisubstituted adenines as A 2A adenosine receptor antagonists.
Lambertucci C; Vittori S; Mishra RC; Dal Ben D; Klotz KN; Volpini R; Cristalli G
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1443-6. PubMed ID: 18066802
[TBL] [Abstract][Full Text] [Related]
3. 8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Lambertucci C; Antonini I; Buccioni M; Dal Ben D; Kachare DD; Volpini R; Klotz KN; Cristalli G
Bioorg Med Chem; 2009 Apr; 17(7):2812-22. PubMed ID: 19282184
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
5. Molecular modelling study of 2-phenylethynyladenosine (PEAdo) derivatives as highly selective A₃ adenosine receptor ligands.
Dal Ben D; Lambertucci C; Taffi S; Vittori S; Volpini R; Cristalli G; Klotz KN
Purinergic Signal; 2006 Nov; 2(4):589-94. PubMed ID: 18404461
[TBL] [Abstract][Full Text] [Related]
6. N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands.
Volpini R; Costanzi S; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
J Med Chem; 2002 Jul; 45(15):3271-9. PubMed ID: 12109910
[TBL] [Abstract][Full Text] [Related]
7. 9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities.
Klotz KN; Kachler S; Lambertucci C; Vittori S; Volpini R; Cristalli G
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):629-34. PubMed ID: 12734636
[TBL] [Abstract][Full Text] [Related]
8. Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists.
Volpini R; Costanzi S; Lambertucci C; Vittori S; Cristalli G
Curr Pharm Des; 2002; 8(26):2285-98. PubMed ID: 12369946
[TBL] [Abstract][Full Text] [Related]
9. Medicinal chemistry and pharmacology of A2B adenosine receptors.
Volpini R; Costanzi S; Vittori S; Cristalli G; Klotz KN
Curr Top Med Chem; 2003; 3(4):427-43. PubMed ID: 12570760
[TBL] [Abstract][Full Text] [Related]
10. New substituted 9-alkylpurines as adenosine receptor ligands.
Camaioni E; Costanzi S; Vittori S; Volpini R; Klotz KN; Cristalli G
Bioorg Med Chem; 1998 May; 6(5):523-33. PubMed ID: 9629466
[TBL] [Abstract][Full Text] [Related]
11. 2- and 8-alkynyl-9-ethyladenines: Synthesis and biological activity at human and rat adenosine receptors.
Volpini R; Costanzi S; Lambertucci C; Vittori S; Martini C; Trincavelli ML; Klotz KN; Cristalli G
Purinergic Signal; 2005 Jun; 1(2):173-81. PubMed ID: 18404502
[TBL] [Abstract][Full Text] [Related]
12. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
Pastorin G; Da Ros T; Spalluto G; Deflorian F; Moro S; Cacciari B; Baraldi PG; Gessi S; Varani K; Borea PA
J Med Chem; 2003 Sep; 46(20):4287-96. PubMed ID: 13678407
[TBL] [Abstract][Full Text] [Related]
13. N6,9-disubstituted adenines: potent, selective antagonists at the A1 adenosine receptor.
Thompson RD; Secunda S; Daly JW; Olsson RA
J Med Chem; 1991 Sep; 34(9):2877-82. PubMed ID: 1895305
[TBL] [Abstract][Full Text] [Related]
14. Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonists.
Müller CE; Thorand M; Qurishi R; Diekmann M; Jacobson KA; Padgett WL; Daly JW
J Med Chem; 2002 Aug; 45(16):3440-50. PubMed ID: 12139454
[TBL] [Abstract][Full Text] [Related]
15. [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors.
Varani K; Merighi S; Gessi S; Klotz KN; Leung E; Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Borea PA
Mol Pharmacol; 2000 May; 57(5):968-75. PubMed ID: 10779381
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
[TBL] [Abstract][Full Text] [Related]
17. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
[TBL] [Abstract][Full Text] [Related]
18. 3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A₂B adenosine receptor antagonists.
Taliani S; Pugliesi I; Barresi E; Simorini F; Salerno S; La Motta C; Marini AM; Cosimelli B; Cosconati S; Di Maro S; Marinelli L; Daniele S; Trincavelli ML; Greco G; Novellino E; Martini C; Da Settimo F
J Med Chem; 2012 Feb; 55(4):1490-9. PubMed ID: 22257095
[TBL] [Abstract][Full Text] [Related]
19. 5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
van Tilburg EW; van der Klein PA; von Frijtag Drabbe Künzel J; de Groote M; Stannek C; Lorenzen A; IJzerman AP
J Med Chem; 2001 Aug; 44(18):2966-75. PubMed ID: 11520205
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
